MedPath

University Hospital Tuebingen

🇩🇪Germany
Ownership
Private
Established
1388-01-01
Employees
-
Market Cap
-
Website
https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)

Phase 2
Completed
Conditions
Dysgerminoma
First Posted Date
2005-09-20
Last Posted Date
2009-02-16
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
108
Registration Number
NCT00204633
Locations
🇩🇪

Medical Center II, University of Tuebingen, Tuebingen, Germany

Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)

Phase 2
Completed
Conditions
Sarcoma, Soft Tissue
First Posted Date
2005-09-20
Last Posted Date
2007-04-20
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
28
Registration Number
NCT00204620
Locations
🇩🇪

Medical center II, University of Tuebingen, Tuebingen, Germany

Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)

Phase 2
Completed
Conditions
Sarcoma, Soft Tissue
First Posted Date
2005-09-20
Last Posted Date
2007-04-20
Lead Sponsor
University Hospital Tuebingen
Registration Number
NCT00204646
Locations
🇩🇪

Medical Center II, University of Tuebingen, Tuebingen, Germany

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

Phase 1
Completed
Conditions
Malignant Melanoma
First Posted Date
2005-09-20
Last Posted Date
2007-04-19
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
20
Registration Number
NCT00204607
Locations
🇩🇪

Department of Dermatology, University of Tübingen, Tübingen, Germany

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Phase 4
Completed
Conditions
Photosensitivity Disorders
Interventions
First Posted Date
2005-09-20
Last Posted Date
2011-08-19
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
418
Registration Number
NCT00204542
Locations
🇩🇪

Dept. of Dermatology, Freiburg, Germany

🇩🇪

Klinik fuer Dermatologie, Venerologie und Allergologie der Charite, Berlin, Germany

🇩🇪

Praxis Priv.-Doz. Dr. med. Dirschka, Wuppertal, Germany

and more 1 locations

Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa

Phase 2
Conditions
Long Term Ventilation
First Posted Date
2005-09-20
Last Posted Date
2006-09-14
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
540
Registration Number
NCT00204685
Locations
🇩🇪

Charité, Universitätsmedizin Berlin, Campus Mitte, Innere Intensivstation, Berlin, Germany

🇩🇪

Universität Charité, Campus Mitte, Anästhesie, Intensivstation, Berlin, Germany

🇩🇪

Universitätsklinikum Erlangen Medizinische Klinik, Intensivstation I, Erlangen, Germany

and more 22 locations

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

Phase 3
Completed
Conditions
Behcet's Disease
Panuveitis
Posterior Uveitis
Retinal Vasculitis
Interventions
Drug: Interferon-alpha2a
First Posted Date
2005-09-14
Last Posted Date
2018-05-17
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
37
Registration Number
NCT00167583
Locations
🇩🇪

Department of Internal Medicine II and Department of Ophthalmology, Tuebingen, Germany

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Phase 2
Completed
Conditions
Peripheral Vascular Diseases
Interventions
First Posted Date
2005-09-13
Last Posted Date
2011-08-09
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
80
Registration Number
NCT00163267
Locations
🇩🇪

University Hospital of Tuebingen, Tuebingen, Germany

Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee

Phase 2
Conditions
Patients Above 18 Years
First Posted Date
2005-09-13
Last Posted Date
2006-09-12
Lead Sponsor
University Hospital Tuebingen
Registration Number
NCT00163254
Locations
🇩🇪

University of Tuebingen, Tuebingen, Germany

Psychological Intervention for Relapse Prevention in First Episode Schizophrenia

Not Applicable
Conditions
Schizophrenic Disorders
First Posted Date
2005-09-12
Last Posted Date
2005-09-12
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
106
Registration Number
NCT00161408
Locations
🇩🇪

Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany

🇩🇪

Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany

🇩🇪

Department of Psychiatry and Psychotherapy, University of Duesseldorf, Duesseldorf, Germany

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath